Review ArticleThe Impact of the COVID-19 Pandemic on Cancer PatientsAl-Quteimat, Osama M. MSc, BCOP*; Amer, Amer Mustafa BSc, MSc†Author Information *Pharmacy Services Department, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE †Inpatient Pharmacist, The Specialty Hospital, Amman, Jordan The authors declare no conflicts of interest. Reprints: Osama M. Al-Quteimat, MSc, BCOP, Pharmacy Services Department, Cleveland Clinic Abu Dhabi, Abu Dhabi 112412, UAE. E-mail: Alquteo@clevelandclinicabudhabi.ae. American Journal of Clinical Oncology: June 2020 - Volume 43 - Issue 6 - p 452-455 doi: 10.1097/COC.0000000000000712 Buy Metrics Abstract In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19). Severe complications have been reported to occur in 33% of patients with COVID-19 and include acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia. Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potential medications to treat COVID-19. The immunosuppressed status of some cancer patients (whether caused by the disease itself or the treatment) increases their risk of infection compared with the general population. This short review aims to focus on the impact of COVID-19 on a cancer patient and discuss management options and recommendation in addition to highlighting the currently available clinical guidelines and resources. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.